Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Intervention: Drug: Exenatide Once-Weekly Suspension Sponsor: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2019 Category: Research Source Type: clinical trials